| scholarly article | Q13442814 |
| P50 | author | Marc Van Ranst | Q2600921 |
| Claudia Balotta | Q28743816 | ||
| Anne-Mieke Vandamme | Q28743834 | ||
| Leondios G Kostrikis | Q56451341 | ||
| Roger Paredes | Q60556297 | ||
| Jurgen Vercauteren | Q64008134 | ||
| Annemarie M J Wensing | Q89876269 | ||
| Inge Derdelinckx | Q114726091 | ||
| Fossie Ferreira | Q114726096 | ||
| Claudia Kücherer | Q47006514 | ||
| Maja Stanojevic | Q55299103 | ||
| Kristel Van Laethem | Q28743837 | ||
| Ricardo Khouri | Q30650237 | ||
| Andrea-Clemencia Pineda-Peña | Q30650239 | ||
| Eric Van Wijngaerden | Q30650339 | ||
| Paul De Munter | Q30650536 | ||
| Yoeri Schrooten | Q30650537 | ||
| Nídia Sequeira Trovão | Q37063257 | ||
| Jan Albert | Q39183357 | ||
| P2093 | author name string | Claus Nielsen | |
| Guangdi Li | |||
| Lore Vinken | |||
| Charles Boucher | |||
| Arley Gomez-Lopez | |||
| Kirsi Littsola | |||
| P2860 | cites work | MUSCLE: multiple sequence alignment with high accuracy and high throughput | Q24613456 |
| BEAST: Bayesian evolutionary analysis by sampling trees | Q27860723 | ||
| RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models | Q27860746 | ||
| MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods | Q27860929 | ||
| Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008 | Q28302612 | ||
| Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update | Q28474918 | ||
| Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population | Q28477624 | ||
| Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010 | Q28481603 | ||
| Transmitted antiretroviral drug resistance in New York State, 2006-2008: results from a new surveillance system | Q28482098 | ||
| Performance of ViroSeq HIV-1 Genotyping System in routine practice at a Belgian clinical laboratory | Q56778415 | ||
| Choosing Appropriate Substitution Models for the Phylogenetic Analysis of Protein-Coding Sequences | Q56877001 | ||
| Phylogenetic Investigation of Transmission Pathways of Drug-Resistant HIV-1 Utilizing Pol Sequences Derived From Resistance Genotyping | Q62022581 | ||
| Estimates of HIV transmitted drug resistance can be inflated due to natural sequence polymorphisms | Q82464090 | ||
| Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece | Q84967514 | ||
| Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium | Q43647453 | ||
| Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan. | Q44035013 | ||
| Transmission of drug-resistant HIV-1 is stabilizing in Europe | Q44591236 | ||
| Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study | Q45057839 | ||
| Transmission network of an HIV type 1 strain with K103N in young Belgian patients from different risk groups | Q45114115 | ||
| Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006. | Q45850523 | ||
| Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey | Q50139327 | ||
| Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008. | Q51606809 | ||
| Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response. | Q53878012 | ||
| HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy. | Q53898514 | ||
| Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination | Q29616724 | ||
| An automated genotyping system for analysis of HIV-1 and other microbial sequences | Q33220974 | ||
| Epidemiological study of phylogenetic transmission clusters in a local HIV-1 epidemic reveals distinct differences between subtype B and non-B infections | Q33686402 | ||
| Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection | Q34228730 | ||
| National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011. | Q34353387 | ||
| Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe | Q34469240 | ||
| Automated analysis of phylogenetic clusters | Q34493132 | ||
| Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response | Q34684386 | ||
| Transmission network parameters estimated from HIV sequences for a nationwide epidemic | Q35238164 | ||
| HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics | Q36588672 | ||
| Limited cross-border infections in patients newly diagnosed with HIV in Europe | Q36766901 | ||
| HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes | Q36905669 | ||
| Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach | Q37278724 | ||
| High rates of forward transmission events after acute/early HIV-1 infection | Q39788342 | ||
| HIV-1 drug resistance transmission networks in southwest Switzerland | Q39835085 | ||
| Transmission of drug-resistant HIV-1 in Europe remains limited to single classes | Q40117320 | ||
| Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance | Q40281796 | ||
| Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools | Q42263635 | ||
| Phylogenetic and demographic characterization of HIV-1 transmission in Madrid, Spain | Q42280008 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug resistance | Q12147416 |
| HIV transmission | Q49029021 | ||
| P304 | page(s) | e101738 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic | |
| P478 | volume | 9 |
| Q38894410 | Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM/TSP outcome |
| Q59355917 | Analysis of HIV-1 infection in a controller-discordant couple |
| Q33829130 | Defining HIV-1 transmission clusters based on sequence data |
| Q64281028 | Discussion on critical points for a tailored therapy to cure hepatitis C virus infection |
| Q90374947 | Drivers of HIV-1 transmission: The Portuguese case |
| Q58377717 | Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000–14 |
| Q64118436 | Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium |
| Q56395674 | Epidemic history of hepatitis C virus genotypes and subtypes in Portugal |
| Q28547497 | Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations |
| Q40133561 | Epidemiological trends of HIV-1 infection in blood donors from Catalonia, Spain (2005-2014). |
| Q56911534 | Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013 |
| Q61815781 | Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort |
| Q37631865 | Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom |
| Q36174668 | The prevalence of drug resistance among treatment-naïve HIV-1-infected individuals in China during pre- and post- 2004 |
| Q90452613 | Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance |
Search more.